SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Roche Obesity Drug Helps Patients Shed 22.7% Of Weight in Mid-stage Trial

Roche said on Friday that patients lost 22.7% of their body weight in a mid-stage trial of its dual-acting experimental obesity ⁠drug, with more than a quarter of those who...

Beyond BMI: New Score Stratifies Obesity Risk

BMI, while useful, is insufficient to identify patients at the highest risk for obesity-related complications. A new tool may help clinicians better stratify risk and target treatment.

Wearables Generate the Data: What's Next for Chronic Care?

Wearable devices are moving beyond fitness tracking, providing clinicians with real-world data that may improve monitoring and continuity of care in chronic disease.

Tango Therapeutics' Pancreatic Cancer Drug Combo Shows Promise in Study

Tango Therapeutics said on Monday an experimental drug combination showed strong early results in a small study of patients ⁠with advanced pancreatic cancer and that it...

Liver-Directed Insulin: A New Way to Reduce Hypoglycemia?

Study findings suggest that a liver-targeted formulation of fast-acting insulin may reduce the risk for hypoglycemia in patients with type 1 diabetes.

Moving Beyond GLP-1s: Preclinical Acceleration, Innovation

Next-generation obesity therapeutics aim to counter weight rebound, decrease side effects, and support weight maintenance.

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Latest News

Roche said on Friday that patients lost 22.7% of their body weight in a mid-stage trial of its dual-acting experimental obesity ⁠drug, with more than a quarter of those who...

BMI, while useful, is insufficient to identify patients at the highest risk for obesity-related complications. A new tool may help clinicians better stratify risk and target treatment.

Wearable devices are moving beyond fitness tracking, providing clinicians with real-world data that may improve monitoring and continuity of care in chronic disease.

Tango Therapeutics said on Monday an experimental drug combination showed strong early results in a small study of patients ⁠with advanced pancreatic cancer and that it...

Study findings suggest that a liver-targeted formulation of fast-acting insulin may reduce the risk for hypoglycemia in patients with type 1 diabetes.

Next-generation obesity therapeutics aim to counter weight rebound, decrease side effects, and support weight maintenance.

News All Time

Primary Infertility Linked to Earlier Menopause Onset

Women with primary infertility undergo natural menopause earlier than women without infertility.

Exclusive-Cigna Drops Coverage Of GLP-1 Obesity Drugs for Its Own Employees

Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee ⁠health plan effective July 1,...

SGLT2 Inhibitors Cut Kidney Events in Nephrotic Proteinuria

In adults with type 2 diabetes and nephrotic-range proteinuria, SGLT2 inhibitors are linked to lower risks for major adverse kidney events and all-cause mortality than DPP-4 inhibitors.

How Cannabis Compounds May Help Create Weight-Loss Drugs

A new study in mice finds that cannabis extracts improve glucose regulation by improving communication between fat cells and the pancreas.

Phase 3: Rapid Relief in Thyroid Eye Disease With Veligrotug

A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows.

Gestational Diabetes May Raise Future Retinopathy Risk

In women with diabetes, a history of gestational diabetes is associated with a higher risk for diabetic retinopathy, with risk increasing as gestational diabetes severity increases.

BMI at Age 6 Predicts Obesity Risk in Young Adulthood

BMI at age 6 strongly predicts the risk for overweight and obesity in young adulthood; children with a high BMI and slower growth between ages 2 and 6 have odds similar to peers with an average BMI.

Gestational GLP-1s Tied to Adverse Obstetric Outcomes

Underlying diabetes and discontinuation rebound in mothers with overweight are likely responsible rather than the drug itself.

Eating Out Exacerbating the Global Obesity Epidemic

Eating out instead of preparing food at home is exacerbating the global obesity epidemic, with half of adults worldwide eating out at least once a week.

GLP-1 Apps: Helpful Companions or False Sense of Security?

GLP-1 consumer apps can help patients stay on track but have no evidence base; clinical-grade apps can do more but are not accessible to most patients.

Fezolinetant Linked to Enzyme Elevations

Fezolinetant is associated with a hepatic adverse event reporting signal characterized primarily by transaminase elevations rather than clinically overt liver injury.

Study Sheds Light on Burden of Rare Bone Disease in France

Fibrous dysplasia or McCune-Albright syndrome affects approximately 5 per 1,000,000 hospitalised patients in France, with higher rates observed among children and women.

Surgery or Meds for Weight Regain After Sleeve Gastrectomy?

A retrospective study finds that conversion surgery after sleeve gastrectomy produces greater long-term weight loss than obesity medications for recurrent weight gain.

The Latest in GLP-1-Based Therapy to be Featured at ADA

New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.

Inhaled Insulin Okayed for Kids With Diabetes Aged 6+ Years

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

Modest Protein Restriction Tied to Better Outcomes in CKD

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

Recommended News For You

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

More cancer cases in areas where incarceration rates are high: Study

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

Recommended Articles For You

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions 

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making 

Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder 

Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

2.

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

3.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Firefighters who eat better can combat cancer.

1.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

2.

Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma

3.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

4.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

5.

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

2.

Navigating the Complexities of Ph Negative ALL - Part V

3.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

4.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot